Levoxigram

Active substance

Levofloxacin

Strenght and pharmaceutical forms

250mg Levoxigram film-coated tablets - 1 / 5 / 7 / 10 tablets
500 mg Levoxigram film-coated tablets - 1 / 5 / 7 / 10 tablets

ATC

J01MA12 - antiinfectives for systemic use - antibacterials for systemic use - quinolone antibacterials - fluoroquinolones

Therapeutic Indications

In adults with mild or moderate infections, Levoxigram tablets are indicated for the treatment of the infections listed below, when these are due to levofloxacin sensitive organisms:
• Acute bacterial sinusitis (adequately diagnosed by reference to national and / or local guidelines on the treatment of respiratory tract infections and when it is inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection or when they have failed) to solve the infection)
• Acute bacterial exacerbations of chronic bronchitis (adequately diagnosed by reference to national and / or local guidelines on treating respiratory infections and when it is inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection or when they failed to resolve the infection)
• Community-acquired pneumonia (when it is inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection)
• Uncomplicated urinary tract infections
• Complicated urinary tract infections (including pyelonephritis)
• Chronic bacterial prostatitis
• Skin and soft tissue infections